ASSET PURCHASE AGREEMENT by and among NABI BIOPHARMACEUTICALS, BIOTEST PHARMACEUTICALS CORPORATION and BIOTEST AG Dated as of September 11, 2007Asset Purchase Agreement • September 11th, 2007 • Nabi Biopharmaceuticals • Biological products, (no disgnostic substances) • New York
Contract Type FiledSeptember 11th, 2007 Company Industry JurisdictionTHIS ASSET PURCHASE AGREEMENT (this “Agreement”), dated as of September 11, 2007 (the “Execution Date”), is entered into by and among Nabi Biopharmaceuticals, a Delaware corporation (“Seller”), Biotest Pharmaceuticals Corporation, a Delaware corporation (“Buyer”), and Biotest AG, a company organized under the laws of Germany (“Parent”). Each of Seller, Buyer and Parent are sometimes referred to herein, individually, as “Parties” and, collectively, as the “Parties.” All capitalized terms used herein shall have the meanings specified in Annex 1.1 or elsewhere in this Agreement, as applicable.